Cleared Traditional

COBAS INTEGRA REAGENT CASSETTES & ANCILLARY REAGENTS (K963292) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K963292 · Roche Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1996
Decision
71d
Days
Class 2
Risk

K963292 is an FDA 510(k) clearance for the COBAS INTEGRA REAGENT CASSETTES & ANCILLARY REAGENTS. Classified as Cresolphthalein Complexone, Calcium (product code CIC), Class II - Special Controls.

Submitted by Roche Diagnostic Systems, Inc. (Somerville, US). The FDA issued a Cleared decision on October 31, 1996 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1145 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Roche Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K963292 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 21, 1996
Decision Date October 31, 1996
Days to Decision 71 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 88d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIC Cresolphthalein Complexone, Calcium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1145
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIC Cresolphthalein Complexone, Calcium

All 98
Devices cleared under the same product code (CIC) and FDA review panel - the closest regulatory comparables to K963292.
IL TEST CALCIUM
K931362 · Instrumentation Laboratory CO · Feb 1994
COBAS READY CALCIUM REAGENT
K896224 · Roche Diagnostic Systems, Inc. · Aug 1990
ABBOTT SPECTRUM(R) CALCIUM REAGENT
K894407 · Abbott Laboratories · Sep 1989
IQ CALCIUM
K891217 · Bd Becton Dickinson Vacutainer Systems Preanalytic · May 1989
PARAMAX CALCIUM REAGENT
K873519 · Baxter Healthcare Corp · Dec 1987
SYSTEM PACK FOR B.M.D/HITACHI 704 CHEM. ANA.(GABA)
K872306 · Boehringer Mannheim Corp. · Aug 1987